Fangusaro Research

Dr. Fangusaro's primary area of research is the development of early phase clinical trials, novel therapeutics and relevant biologic correlates in an effort to improve survival outcomes and minimize toxicities. Within pediatric brain tumors, his research has focused on two main areas: low grade gliomas (LGG) and central nervous system (CNS) germ cell tumors (GCTs). He has and currently leads large prospective multi-institutional trials specifically focused on these 2 tumor types. 

He is a member of both the LGG and CNS GCTs international consensus panels, and also serves as the principal investigator and co-investigator on numerous national trials. As part of his role as the Director of Developmental Therapeutics in Oncology, he oversees the team that coordinate early phase trials in all pediatric oncology patients, including solid tumors and leukemia and lymphoma.